- Home
- ALG vs PTGX Comparison
ALG vs PTGX Comparison
Compare ALG & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALG
- PTGX
- Stock Information
- Founded
- ALG 1955
- PTGX 2006
- Country
- ALG United States
- PTGX United States
- Employees
- ALG N/A
- PTGX N/A
- Industry
- ALG Industrial Machinery/Components
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- ALG Industrials
- PTGX Health Care
- Exchange
- ALG Nasdaq
- PTGX Nasdaq
- Market Cap
- ALG 2.6B
- PTGX 3.3B
- IPO Year
- ALG 1993
- PTGX 2016
- Fundamental
- Price
- ALG $226.21
- PTGX $51.25
- Analyst Decision
- ALG Buy
- PTGX Strong Buy
- Analyst Count
- ALG 2
- PTGX 9
- Target Price
- ALG $186.00
- PTGX $67.11
- AVG Volume (30 Days)
- ALG 156.7K
- PTGX 1.0M
- Earning Date
- ALG 07-30-2025
- PTGX 08-05-2025
- Dividend Yield
- ALG 0.53%
- PTGX N/A
- EPS Growth
- ALG N/A
- PTGX N/A
- EPS
- ALG 9.60
- PTGX 0.86
- Revenue
- ALG $1,593,877,000.00
- PTGX $207,801,000.00
- Revenue This Year
- ALG $0.52
- PTGX N/A
- Revenue Next Year
- ALG $5.01
- PTGX $47.15
- P/E Ratio
- ALG $23.56
- PTGX $59.19
- Revenue Growth
- ALG N/A
- PTGX N/A
- 52 Week Low
- ALG $157.07
- PTGX $32.50
- 52 Week High
- ALG $227.00
- PTGX $60.60
- Technical
- Relative Strength Index (RSI)
- ALG 74.56
- PTGX 45.80
- Support Level
- ALG $215.42
- PTGX $49.86
- Resistance Level
- ALG $219.85
- PTGX $57.24
- Average True Range (ATR)
- ALG 4.22
- PTGX 2.06
- MACD
- ALG 0.22
- PTGX -0.78
- Stochastic Oscillator
- ALG 95.46
- PTGX 16.14
About ALG Alamo Group Inc.
Alamo Group Inc is engaged in the design, manufacture, and servicing of high-quality vegetation management and infrastructure maintenance equipment for governmental, industrial and agricultural use. Its products include tractor-mounted and self-propelled mowers, zero-turn mowers, agricultural implements, tree and branch chippers, forestry/wood recycling equipment, street and parking lot sweepers, leaf and debris collection equipment, truck mounted highway attenuator trucks, vacuum trucks, hydro-excavation equipment, telescopic boom excavators, and snow removal equipment. The company's reportable segments are Vegetation Management and Industrial Equipment. It generates a majority of revenue from Vegetation Management. Geographically, it generates the majority of revenue from United States.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.